Critical Care Issues in Oncological Surgery Patients

Critical Care Clinics

Volumn 26, Issue 1, 2010, Pages 93-106

  Ahmed, Sanam ^a   Oropello, John M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Chemotherapy; Cytoreductive; ICU

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CHLORHEXIDINE GLUCONATE; CISPLATIN; CONTRAST MEDIUM; CYTOTOXIC AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOXORUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOSTATIC AGENT; HYPERTENSIVE FACTOR; INOTROPIC AGENT; MITOMYCIN C; OXALIPLATIN; PROTON PUMP INHIBITOR;

ABDOMINAL BLEEDING; ABSCESS; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; ANASTOMOSIS LEAKAGE; ARTIFICIAL VENTILATION; BLEEDING; BLOOD CLOTTING DISORDER; BONE MARROW SUPPRESSION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CENTRAL VENOUS PRESSURE; CHRONIC DISEASE; CRITICALLY ILL PATIENT; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG DOSE INCREASE; ENDOTRACHEAL INTUBATION; ENTERIC FEEDING; HEMODYNAMICS; HUMAN; INTENSIVE CARE; INTESTINE PERFORATION; LEUKOPENIA; LIFE EXPECTANCY; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; NEPHROTOXICITY; OVERALL SURVIVAL; PATIENT CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RESPIRATORY FAILURE; RESUSCITATION; REVIEW; SURGICAL APPROACH; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; VASCULAR ACCESS; VENOUS THROMBOEMBOLISM;

ABDOMINAL NEOPLASMS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; CRITICAL CARE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; INTENSIVE CARE UNITS; PERITONEAL NEOPLASMS; SEPSIS; SURGICAL PROCEDURES, OPERATIVE;

EID: 70449789067     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.10.004     Document Type: Review

References (60)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
2. Darmon M., and Azoulay E. Critical care management of cancer patients: cause for optimism and need for objectivity. Curr Opin Oncol 21 (2009) 318-326
3. Soares M., Salluh J.I., Torres V.B., et al. Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay. Chest 134 (2008) 520-526
4. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
5. De Roover A., Detroz B., Detry O., et al. Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience. Acta Chir Belg 106 (2006) 297-301
6. Jaehne J. Cytoreductive procedures-strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks. J Surg Oncol 100 (2009) 302-305
7. Esquivel J. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea. Cancer J 15 (2009) 249-254
8. Esquivel J., Angulo F., Bland R.K., et al. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open "coliseum technique". Ann Surg Oncol 7 (2000) 296-300
9. Foltz P., Wavrin C., and Sticca R. Heated intraoperative intraperitoneal chemotherapy-the challenges of bringing chemotherapy into surgery. AORN J 80 (2004) 1055-1063 [quiz 65-8]
10. Schmidt C., Creutzenberg M., Piso P., et al. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia 63 (2008) 389-395
11. Fujimura T., Yonemura Y., Nakagawara H., et al. Subtotal peritonectomy with chemohyperthermic peritoneal perfusion for peritonitis carcinomatosa in gastrointestinal cancer. Oncol Rep 7 (2000) 809-814
12. Schmidt C., Moritz S., Rath S., et al. Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol 100 (2009) 297-301
13. Pavlov M.J., Kovacevic P.A., Ceranic M.S., et al. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer-12-year single center experience. Eur J Surg Oncol 35 (2009) 1186-1191
14. Spratt J.S., Adcock R.A., Muskovin M., et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40 (1980) 256-260
15. Katayama K., Yamaguchi A., Murakami M., et al. Chemo-hyperthermic peritoneal perfusion (CHPP) for appendiceal pseudomyxoma peritonei. Int J Clin Oncol 14 (2009) 120-124
16. Hesdorffer M.E., Chabot J.A., Keohan M.L., et al. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma. Am J Clin Oncol 31 (2008) 49-54
17. Helm C.W., Toler C.R., Martin III R.S., et al. Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity. Int J Gynecol Cancer 17 (2007) 204-209
18. Piso P., Glockzin G., von Breitenbuch P., et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies. J Surg Oncol 100 (2009) 317-320
19. Chu D.Z., Lang N.P., Thompson C., et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63 (1989) 364-367
20. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
21. Esquivel J., Elias D., Baratti D., et al. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98 (2008) 263-267
22. Younan R., Kusamura S., Baratti D., et al. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 98 (2008) 253-257
23. van Leeuwen B.L., Graf W., Pahlman L., et al. Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol 15 (2008) 745-753
24. Bijelic L., Jonson A., and Sugarbaker P.H. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18 (2007) 1943-1950
25. Shehata M., Chu F., Saunders V., et al. Peritoneal carcinomatosis from colorectal cancer and small bowel cancer treated with peritonectomy. ANZ J Surg 76 (2006) 467-471
26. Loggie B.W., Fleming R.A., McQuellon R.P., et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 66 (2000) 561-568
27. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
28. Jacquet P., Stephens A.D., Averbach A.M., et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer 77 (1996) 2622-2629
29. Sugarbaker P.H., and Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58 (2000) 96-107
30. Witkamp A.J., de Bree E., Van Goethem R., et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27 (2001) 365-374
31. Glockzin G., Schlitt H.J., and Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7 (2009) 5
32. Mort T.C. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts. Anesth Analg 99 (2004) 607-613
33. Mulcaster J.T., Mills J., Hung O.R., et al. Laryngoscopic intubation: learning and performance. Anesthesiology 98 (2003) 23-27
34. Nouruzi-Sedeh P., Schumann M., and Groeben H. Laryngoscopy via Macintosh blade versus GlideScope: success rate and time for endotracheal intubation in untrained medical personnel. Anesthesiology 110 (2009) 32-37
35. Lange M., Frommer M., Redel A., et al. Comparison of the Glidescope and Airtraq optical laryngoscopes in patients undergoing direct microlaryngoscopy. Anaesthesia 64 (2009) 323-328
36. Fernandez-Perez E.R., Sprung J., Afessa B., et al. Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study. Thorax 64 (2009) 121-127
37. Doelken P., Abreu R., Sahn S.A., et al. Effect of thoracentesis on respiratory mechanics and gas exchange in the patient receiving mechanical ventilation. Chest 130 (2006) 1354-1361
38. Mayo P.H., Beaulieu Y., Doelken P., et al. American College of Chest Physicians/La Societe de Reanimation de Langue Francaise statement on competence in critical care ultrasonography. Chest 135 (2009) 1050-1060
39. Liang S.J., Tu C.Y., Chen H.J., et al. Application of ultrasound-guided pigtail catheter for drainage of pleural effusions in the ICU. Intensive Care Med 35 (2009) 350-354
40. Chockalingam A., Dorairajan S., Bhalla M., et al. Unexplained hypotension: the spectrum of dynamic left ventricular outflow tract obstruction in critical care settings. Crit Care Med 37 (2009) 729-734
41. Marik P.E. Techniques for assessment of intervascular volume in critically ill patients. J Intensive Care Med 24 (2009) 329-337
42. Marik P.E., Baram M., and Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 134 (2008) 172-178
43. Marecaux G., Pinsky M.R., Dupont E., et al. Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med 22 (1996) 404-408
44. Cuschieri J., Rivers E.P., Donnino M.W., et al. Central venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med 31 (2005) 818-822
45. van Beest P.A., Hofstra J.J., Schultz M.J., et al. The incidence of low venous oxygen saturation on admission to the intensive care unit: a multi-center observational study in The Netherlands. Crit Care 12 (2008) R33
46. Sugarbaker P.H., Alderman R., Edwards G., et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 13 (2006) 635-644
47. Bruno J.J., Canada T.W., Wakefield C.D., et al. Stress-related mucosal bleeding in critically ill oncology patients. J Oncol Pharm Pract 15 (2009) 9-16
48. Eisen L.A., Narasimhan M., Berger J.S., et al. Mechanical complications of central venous catheters. J Intensive Care Med 21 (2006) 40-46
49. Denys B.G., Uretsky B.F., and Reddy P.S. Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation 87 (1993) 1557-1562
50. Gowardman J.R., Robertson I.K., Parkes S., et al. Influence of insertion site on central venous catheter colonization and bloodstream infection rates. Intensive Care Med 34 (2008) 1038-1045
51. Foster P.F., Moore L.R., Sankary H.N., et al. Central venous catheterization in patients with coagulopathy. Arch Surg 127 (1992) 273-275
52. Doerfler M.E., Kaufman B., and Goldenberg A.S. Central venous catheter placement in patients with disorders of hemostasis. Chest 110 (1996) 185-188
53. DeLoughery T.G., Liebler J.M., Simonds V., et al. Invasive line placement in critically ill patients: do hemostatic defects matter?. Transfusion 36 (1996) 827-831
54. Weigand K., Encke J., Meyer F.J., et al. Low levels of prothrombin time (INR) and platelets do not increase the risk of significant bleeding when placing central venous catheters. Med Klin (Munich) 104 (2009) 331-335
55. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 (2002) 1-29
56. Timsit J.F., Schwebel C., Bouadma L., et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 301 (2009) 1231-1241
57. Helm C.W., Randall-Whitis L., Martin III R.S., et al. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol 105 (2007) 90-96
58. Lanuke K., Mack L.A., and Temple W.J. A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Can J Surg 52 (2009) 18-22
59. August D.A., and Huhmann M.B. American Society for Parenteral and Enteral Nutrition A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 33 (2009) 472-500
60. Braga M., Ljungqvist O., Soeters P., et al. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr 28 (2009) 378-386